NovoMAb-G2 human monoclonal antibody: NVO this year will begin Phase I studies of the human MAb

Novopharm Biotech Inc. (VSE:NVO), Toronto, Ontario Product: NovoMAb-G2 human monoclonal antibody Indication: Melanoma Status: NVO this year will begin Phase I studies of the human MAb targeted at a ne...